AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
NEW DELHI, Sept 1 Asia Pulse - Global pharma giant Pfizer on Friday said it has won a legal battle in Denmark in its ongoing patent litigation over anti-cholesterol drug, Lipitor with Ranbaxy Laboratories (BSE:500359).
The Eastern Division of the High Court in Copenhagen, Denmark had ruled in the company's favour which challenged two of its patents covering atorvastatin, the active ingredient in Lipitor, Pfizer said in a statement.
The court ruled that the basic patent, which expires in November 2011, would be infringed by Ranbaxy's generic atorvastatin product, it added.
The decision, which is subject to possible appeal, prevents Ranbaxy from launching its generic product before November 2011, it said.
"on Friday's decision is an important outcome for Pfizer and other medical innovators who invest in high-risk research to develop life-saving medicines for ...